Erosive Esophagitis (EE) Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 384100|Published date: 14 November, 2024
Exocrine Pancreatic Insufficiency Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 438269|Published date: 14 November, 2024
Excessive Daytime Sleepiness (EDS) Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 524347|Published date: 14 November, 2024
Ewing Sarcoma Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 700947|Published date: 14 November, 2024
Essential Thrombocythemia (ET) Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 862053|Published date: 14 November, 2024
ESR1 Mutated Metastatic Breast Cancer Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 252467|Published date: 14 November, 2024
Esophageal Cancer Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 348157|Published date: 14 November, 2024
Epstein–Barr Virus (EBV) Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 725948|Published date: 14 November, 2024
Epilepsy Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 385893|Published date: 14 November, 2024
Epidermolysis Bullosa Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 752963|Published date: 13 November, 2024
Ependymoma Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 281751|Published date: 13 November, 2024
Eosinophilic Granulomatosis with Polyangiitis Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 701371|Published date: 13 November, 2024